Oral TPOXX®
TPOXX® is a small molecule therapy delivered to the Strategic National Stockpile (SNS) under Project BioShield, as an antiviral agent specifically indicated for the treatment of smallpox. Also known as ST-246.
Availability: Commercially Available
| Manufacturer |
| SIGA Technologies, Inc. |
| Product Name |
| Oral TPOXX® |
| Detection Category |
| Biological |
| Detection Method |
| Medical Countermeasure; |
| Application |
| Personal Protective Equipment; |
| Equipment Type |
| PPE |
| Product Synopsis |
| TPOXX® is a small molecule therapy delivered to the Strategic National Stockpile (SNS) under Project BioShield, as an antiviral agent specifically indicated for the treatment of smallpox. Also known as ST-246. |
| Availability |
| Commercially Available |
| Technology Readiness Level (TRL) |
| 9 |
| User Feedback Sources |
| Indifferent/No user feedback |
| Supporting Documentation |
| Docs: TPOXX-Fact-Sheet.pdf; |
| Weight |
| <1 lb. |
| Power Requirements |
| None |
| Transportability |
| Pocket Size |
| Training Required |
| <1 hour training |
| Training Available |
| Yes |
| Manuals Available |
| Yes |